SPI Pharmaceuticals Inc.: The Costa Mesa drug...

SPI Pharmaceuticals Inc.: The Costa Mesa drug maker and distributor said its second-quarter profit increased to $5.2 million, or 25 cents a share, from $1.1 million, or 5 cents a share, for the same period a year earlier. Sales were up 19% to $78.9 million from $66.4 million. For the first half, the company’s profit doubled to $13.6 million, or 65 cents a share, from $6.8 million, or 34 cents a share, for the same period a year earlier. Six-month sales declined 19% to $151.1 million from $186.1 million.